Welcome to ACCP Learning Management System
Access all your CE needs here!
Upcoming live webinars are listed below
To view the entire CE catalog, click on Catalog in the box to the right
To view CE products that you have already purchased, click on Dashboard in the box to the right. You need to be logged in to view your Dashboard
If you need assistance, email firstname.lastname@example.org or phone 571-291-3493 ext 2
Upcoming Live Webinars
2021 ACCP Virtual Journal Club Webinar-November | Effect of Hepatic Impairment on Cobimetinib Pharmacokinetics: The Complex Interplay Between Physiological Changes and Drug Characteristics-LIVEIncludes a Live Web Event on 11/17/2021 at 2:00 PM (EST)
Cobimetinib is a kinase inhibitor indicated for use in combination with vemurafenib for treatment of unresectable/metastatic melanoma with specific BRAF mutations. Cobimetinib is extensively metabolized in liver; thus, patients with hepatic impairment (HI) might have increased cobimetinib exposure. By attending this educational activity, you will learn about the impact of HI on the pharmacokinetics (PK) and safety of cobimetinib.
2019 ACCP Journal of Clinical Pharmacology Journal CE | Monthly CE Offerings
The American College of Clinical Pharmacology® monthly journal article continuing education offerings from The Journal of Clinical Pharmacology.
2019 ACCP Virtual Journal Club March | Calcineurin Inhibitor and Nonsteroidal Anti-inflammatory Drug Interaction: Implications of Changes in Renal Function Associated With Concurrent Use - ON DEMAND
Presented by: Luke Delzer, PharmD, Clinical Pharmacist, Kaiser Permanente
2019 ACCP Virtual Journal Club January | Suggestions for Model-informed Precision Dosing to Optimize Neonatal Drug Therapy - ON DEMAND
Presented by: Alexander Vinks, PharmD, PhD, FCP, Professor and Div Director, Cincinnati Children’s Hosp Medical Ctr, Clinical Pharmacology and Henry Akinbi, MD, Director of Education, Cincinnati Children’s Hosp Medical Ctr, Perinatal Inst
2018 ACCP Virtual Journal Club November | Precision Oncology Medicine: The Clinical Relevance of Patient‐specific Biomarkers Used to Optimize Cancer Treatment - ON DEMAND
Presented by: William D. Figg, PharmD, Senior Investigator, Natl Cancer Inst of the Natl Inst of Health, Molecular and Clinical Pharmacology Program. Learners that complete this course will be able to provide a comprehensive overview of clinically-relevant biomarkers and molecular profiling platforms in precision oncology medicine to optimize cancer treatment outcomes.
|Access Date||Quiz Result||Score||Actions|